The company said Chair and Chief Executive Officer Christopher E. Kubasik established a written pre-arranged plan on April 28, 2025 for the exercise of stock options and the sale of common shares issued upon exercise (the Plan).

1. 01

   The company said Chair and Chief Executive Officer Christopher E. Kubasik established a written pre-arranged plan on April 28, 2025 for the exercise of stock options and the sale of common shares issued upon exercise (the Plan).

2. 02

   The company said the Plan covers vested options to purchase up to 147,411 shares granted to Kubasik in 2017, which expire in 2027.

3. 03

   The company said shares underlying unexercised options will be sold on predetermined dates starting in July 2025 and ending no later than September 9, 2025, subject to minimum price thresholds in the Plan. It said Kubasik will have no discretion over sales.

4. 04

   The company said Kubasik's ownership interest is considerably in excess of its stock ownership guidelines. It said transactions under the Plan will be disclosed through Form 4 and Form 144 filings, as applicable.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.